Details for New Drug Application (NDA): 090094
✉ Email this page to a colleague
NDA 090094 describes DIDANOSINE, which is a drug marketed by Aurobindo Pharma, Barr, Norvium Bioscience, and Aurobindo, and is included in five NDAs. Additional details are available on the DIDANOSINE profile page.
The generic ingredient in DIDANOSINE is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
The generic ingredient in DIDANOSINE is didanosine. There are eight drug master file entries for this compound. Additional details are available on the didanosine profile page.
Summary for 090094
| Tradename: | DIDANOSINE |
| Applicant: | Aurobindo Pharma |
| Ingredient: | didanosine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 090094
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 125MG | ||||
| Approval Date: | Sep 24, 2008 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 200MG | ||||
| Approval Date: | Sep 24, 2008 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | 250MG | ||||
| Approval Date: | Sep 24, 2008 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
